{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:10:12Z","timestamp":1760155812003,"version":"build-2065373602"},"reference-count":20,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,10,11]]},"DOI":"10.1248\/bpb.b25-00327","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:30Z","timestamp":1760134110000},"page":"1533-1539","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial Coenzyme Q&lt;sub&gt;10&lt;\/sub&gt; Delivery Improves Energy Production in Rat Cardiac Myoblasts and Duchenne Muscular Dystrophy Model Rat Cardiomyocytes"],"prefix":"10.1248","volume":"48","author":[{"given":"Itsumi","family":"Sato","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060\u20130812, Japan"},{"name":"Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060\u20130812, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060\u20130812, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Abe","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060\u20130812, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113\u20138657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Takeda","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060\u20130812, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma","family":"Yamada","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060\u20130812, Japan"},{"name":"Fusion Oriented Research for Disruptive Science and Technology (FOREST) Program, Japan Science and Technology Agency (JST) Japan, Saitama 332\u20130012, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Honka H, Solis-Herrera C, Triplitt C, Norton L, Butler J, DeFronzo RA. Therapeutic manipulation of myocardial metabolism: JACC State-of-the-Art review. <i>J. Am. Coll. Cardiol.<\/i>, <b>77<\/b>, 2022\u20132039 (2021).","DOI":"10.1016\/j.jacc.2021.02.057"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kang C, Badr MA, Kyrychenko V, Eskelinen EL, Shirokova N. Deficit in PINK1\/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. <i>Cardiovasc. Res.<\/i>, <b>114<\/b>, 90\u2013102 (2018).","DOI":"10.1093\/cvr\/cvx201"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Meyers TA, Townsend D. Cardiac pathophysiology and the future of cardiac therapies in duchenne muscular dystrophy. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 4098 (2019).","DOI":"10.3390\/ijms20174098"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tsujioka T, Sasaki D, Takeda A, Harashima H, Yamada Y. Resveratrol-encapsulated mitochondria-targeting liposome enhances mitochondrial respiratory capacity in myocardial cells. <i>Int. J. Mol. Sci.<\/i>, <b>23<\/b>, 112 (2021).","DOI":"10.3390\/ijms23010112"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sato I, Hibino M, Takeda A, Harashima H, Yamada Y. Activation of mitochondrial oxygen consumption rate by delivering coenzyme Q<sub>10<\/sub> to mitochondria of rat skeletal muscle cell (L6). <i>J. Pharm. Sci.<\/i>, <b>113<\/b>, 1836\u20131843 (2024).","DOI":"10.1016\/j.xphs.2024.01.020"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Satrialdi, Munechika R, Biju V, Takano Y, Harashima H, Yamada Y. The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrin-type photosensitizer in combination with MITO-Porter. <i>Chem. Commun.<\/i>, <b>56<\/b>, 1145\u20131148 (2020).","DOI":"10.1039\/C9CC08563G"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yamada Y, Akita H, Kamiya H, Kogure K, Yamamoto T, Shinohara Y, Yamashita K, Kobayashi H, Kikuchi H, Harashima H. MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria <i>via<\/i> membrane fusion. <i>Biochim. Biophys. Acta Biomembr.<\/i>, <b>1778<\/b>, 423\u2013432 (2008).","DOI":"10.1016\/j.bbamem.2007.11.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hibino M, Yamada Y, Fujishita N, Sato Y, Maeki M, Tokeshi M, Harashima H. The use of a microfluidic device to encapsulate a poorly water-soluble drug CoQ<sub>10<\/sub> in lipid nanoparticles and an attempt to regulate intracellular trafficking to reach mitochondria. <i>J. Pharm. Sci.<\/i>, <b>108<\/b>, 2668\u20132676 (2019).","DOI":"10.1016\/j.xphs.2019.04.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hibino M, Filosi T, Carrion LL, Porcu E, Malhotra A, L\u00fcdtke-Buzug K, Ibrahim SM, Yamada Y, Hirose M. An effective approach to modulate mitochondrial function in murine primary macrophages by a mitochondria-targeted nanocapsule, MITO-Porter. <i>Biomed. Pharmacother.<\/i>, <b>186<\/b>, 118019 (2025).","DOI":"10.1016\/j.biopha.2025.118019"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakamura K, Fujii W, Tsuboi M, Tanihata J, Teramoto N, Takeuchi S, Naito K, Yamanouchi K, Nishihara M. Generation of muscular dystrophy model rats with a CRISPR\/Cas system. <i>Sci. Rep.<\/i>, <b>4<\/b>, 5635 (2014).","DOI":"10.1038\/srep05635"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sato I, Sasaki D, Abe J, Yamanouchi K, Takeda A, Yamada Y. Improvement of mitochondrial function in Duchenne muscular dystrophy skeletal muscle cells by coenzyme Q10 delivery to mitochondria. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>771<\/b>, 152003 (2025).","DOI":"10.1016\/j.bbrc.2025.152003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yamada Y, Satrialdi, Hibino M, Sasaki D, Abe J, Harashima H. Power of mitochondrial drug delivery systems to produce innovative nanomedicines. <i>Adv. Drug Deliv. Rev.<\/i>, <b>154-155<\/b>, 187\u2013209 (2020).","DOI":"10.1016\/j.addr.2020.09.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lomis N, Sarfaraz ZK, Alruwaih A, Westfall S, Shum-Tim D, Prakash S. Albumin nanoparticle formulation for heart-targeted drug delivery: <i>in vivo<\/i> assessment of congestive heart failure. <i>Pharmaceuticals<\/i>, <b>14<\/b>, 697 (2021).","DOI":"10.3390\/ph14070697"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Carlsson L, Clarke JC, Yen C, <i>et al<\/i>. Biocompatible, Purified VEGF-A mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine. <i>Mol. Ther. Methods Clin. Dev.<\/i>, <b>9<\/b>, 330\u2013346 (2018).","DOI":"10.1016\/j.omtm.2018.04.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sahoo S, Kariya T, Ishikawa K. Targeted delivery of therapeutic agents to the heart. <i>Nat. Rev. Cardiol.<\/i>, <b>18<\/b>, 389\u2013399 (2021).","DOI":"10.1038\/s41569-020-00499-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tang J, Su T, Huang K, <i>et al<\/i>. Targeted repair of heart injury by stem cells fused with platelet nanovesicles. <i>Nat. Biomed. Eng.<\/i>, <b>2<\/b>, 17\u201326 (2018).","DOI":"10.1038\/s41551-017-0182-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Cheng K, Shen D, Hensley MT, Middleton R, Sun B, Liu W, De Couto G, Marb\u00e1n E. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. <i>Nat. Commun.<\/i>, <b>5<\/b>, 4880 (2014).","DOI":"10.1038\/ncomms5880"},{"key":"18","unstructured":"18) Sato I, Shiraishi M, Norota K, Shiraki K, Yamada Y. Mitochondrial activation and therapeutics: innovations in cell- and organelle-specific medicine. <i>Biol. Pharm. Bull.<\/i>, (2025), in press."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Maruo Y, Shiraishi M, Hibino M, Abe J, Takeda A, Yamada Y. Activation of mitochondria in mesenchymal stem cells by mitochondrial delivery of coenzyme Q<sub>10<\/sub>. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1415\u20131421 (2024).","DOI":"10.1248\/bpb.b24-00284"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Fujikura Y, Kimura K, Yamanouchi K, Sugihara H, Hatakeyama M, Zhuang H, Abe T, Daimon M, Morita H, Komuro I, Oishi K. A medium-chain triglyceride containing ketogenic diet exacerbates cardiomyopathy in a CRISPR\/Cas9 gene-edited rat model with Duchenne muscular dystrophy. <i>Sci. Rep.<\/i>, <b>12<\/b>, 11580 (2022).","DOI":"10.1038\/s41598-022-15934-9"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00327\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T03:41:13Z","timestamp":1760154073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00327\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00327","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"article-number":"b25-00327"}}